Predictive value of serum uric acid levels on mortality in acute coronary syndrome patients with chronic kidney disease after drug-eluting stent implantation

Cardiology (Switzerland)

Volumn 125, Issue 4, 2013, Pages 204-212

  Yin, Zhaoxia ^a,c   Fang, Zhe ^b   Yang, Ming ^a   Du, Xueping ^a   Nie, Bin ^b   Gao, Kang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Acute coronary syndrome; Chronic kidney disease; Drug eluting stent; Survival; Uric acid

Indexed keywords

BIOLOGICAL MARKER; URIC ACID;

ACUTE CORONARY SYNDROME; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; URIC ACID BLOOD LEVEL; ADULT; CARDIOVASCULAR MORTALITY; HAZARD RATIO; PROGNOSIS;

AGED; ANGINA, UNSTABLE; BRAIN DISEASES; CHINA; DRUG-ELUTING STENTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URIC ACID;

EID: 84879148267     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000350953     Document Type: Article

References (35)

1. Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Tamura H, Kojima T, Yokoyama K, Kurata T, Daida H: Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Nephrol Dial Transplant 2011; 26: 2906-2911.
2. Bevc S, Penko M, Kanic V, Hojs R: Mortality of patients with renal dysfunction after percutaneous coronary intervention. Angiology 2010; 61: 24-30.
3. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin Ö, Cosgun SM, Oguzhan A, Eren M, Gibson CM: Prognostic value of uricacid in patients with ST-elevated myocardial infarction undergoing primary coronaryintervention. Am J Cardiol 2012; 109: 486-491.
4. Ndrepepa G, Braun S, Haase HU, Schulz S, Ranftl S, Hadamitzky M, Mehilli J, Schömig A, Kastrati A: Prognostic value of uric acid in patients with acute coronary syndromes. Am J Cardiol 2012; 109: 1260-1265.
5. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V: Uric acid and long-term outcomes in CKD. Am J Kidney Dis 2009; 53: 796-803.
6. Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA: Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis 2011; 58: 398-408.
7. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944. (Pubitemid 44484685)
8. Cai Z, Xu X, Wu X, Zhou C, Li D: Hyperuricemia and the metabolic syndrome in Hangzhou. Asia Pac J Clin Nutr 2009; 18: 81-87.
9. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT: Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007; 194: 214-221.
10. Lee MS, Lin SC, Chang HY, Lyu LC, Tsai KS,Pan WH: High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr 2005; 14: 285-292.
11. Ifudu O, Tan CC, Dulin AL, Delano BG, Friedman EA: Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases. Am J Kidney Dis 1994; 23: 347-351. (Pubitemid 24081371)
12. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY: Serum uric acid levels show a 'Jshaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 457-462.
13. Kim SY, Guevara JP, Kim KM, Choi H, Heitjan DF, Albert DA: Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2010; 62: 170-180.
14. Okura T, Higaki J, Kurata M, Irita J, Miyoshi K, Yamazaki T, Hayashi D, Kohro T: Elevated serum uric acid is an independent predictorfor cardiovascular events in patients with severe coronary artery stenosis. Subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 2009; 73: 885-891.
15. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S: Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology 2009; 114: 300-305.
16. Spoon DB, Lerman A, Rule AD, Prasad A, Lennon RJ, Holmes DR, Rihal CS: The association of serum uric acid levels with outcomes following percutaneous coronary intervention. J Interv Cardiol 2010; 23: 277-283.
17. Suliman ME, Johnson RJ, García-López E, Qureshi AR, Molinaei H, Carrero JJ, Heimbürger O, Bárány P, Axelsson J, Lindholm B, Stenvinkel P: J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006; 48: 761-771. (Pubitemid 44740052)
18. Latif W, Karaboyas A, Tong L, Winchester JF, Arrington CJ, Pisoni RL, Marshall MR, Kleophas W, Levin NW, Sen A, Robinson BM, Saran R: Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol 2011; 6: 2470-2477.
19. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ: The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis 2008; 51: 212-223.
20. Navaneethan SD, Beddhu S: Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant 2009; 24: 1260-1266.
21. Madero M, Sarnak MJ, Wang XL, Greene T, Beck GJ, Kusek JW: Uric acid and long-term outcomes in CKD. Am J Kidney Dis 2009; 53: 796-803.
22. Mazza A, Pessina AC, Pavei A, Scarpa R, Tikhonoff V, Casiglia E: Predictors of stroke mortality in elderly people from the general population. Eur J Epidemiol 2001; 17: 1097-1104.
23. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT: Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin- Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005; 183: 147-155.
24. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH: Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61: 225-232.
25. Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H: The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol 2007; 18: 1893-1897.
26. Heras M, Fernández-Reyes MJ, Sánchez R,Molina Á, Rodríguez A, Álvarez-Ude F: Serum uric acid as a marker of all-cause mortality in an elderly patient cohort. Nefrologia 2012; 32: 67-72.
27. Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H: Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control 2007; 18: 1021-1029. (Pubitemid 47237964)
28. Akpek M, Kaya MG, Uyarel H, Yarlioglues M, Kalay N, Gunebakmaz O, Dogdu O, Ardic I, Elcik D, Ergelen M, Sahin Ö, Oguzhan A, Ergin A, Gibson CM: The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis 2011; 219: 334-341.
29. Filippatos GS, Ahmed M, Gladden JD, Mujib M, Aban IB, Love TE, Sanders PW, Pitt B, Anker SD, Ahmed A: Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 2011; 32: 712-720.
30. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H: Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008; 54: 273-284. (Pubitemid 351302628)
31. Filiopoulos V, Hadjiyannakos D, Vlassopoulos D: New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail 2012; 34: 510-520.
32. Mok Y, Lee SJ, Kim MS, Cui W, Moon YM, Jee SH: Serum uric acid and chronic kidney disease: the Severance cohort study. Nephrol Dial Transplant 2012; 27: 1831-1835.
33. Liu WC, Hung CC, Chen SC, Yeh SM, LinMY, Chiu YW, Kuo MC, Chang JM, Hwang SJ, Chen HC: Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2012; 7: 541-548.
34. Inrig JK, Patel UD, Briley LP, She L, Gillespie BS, Easton JD, Topol EJ, Szczech LA: Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol Dial Transplant 2008; 23: 934-940. (Pubitemid 351767559)
35. Athyros VG, Karagiannis A, Ganotakis ES, Paletas K, Nicolaou V, Bacharoudis G, Tziomalos K, Alexandrides T, Liberopoulos EN, Mikhailidis DP: Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin 2011; 27: 1659-1668.